Assessment of the safety of long-acting β<inf>2</inf> -agonists in routine asthma care : The ASTRO-LAB protocol
Citation
Van Ganse , E , Texier , N , Dima , A L , Laforest , L , Ferrer , M , Hernandez , G , Schuck , S , Herbage , S , Vial , D & De Bruin , M 2015 , ' Assessment of the safety of long-acting β <inf >2 </inf > -agonists in routine asthma care : The ASTRO-LAB protocol ' , npj Primary Care Respiratory Medicine , vol. 25 , 15040 . https://doi.org/10.1038/npjpcrm.2015.40